Award of a £1.2 million development contract by General Dynamics as part of the new SV vehicle for the UK Ministry of Defence

By: Bioquell  05-Apr-2012
Keywords: Life Sciences, Defence Sectors

  • Award of a £1.2 million development contract as part of the new SV vehicle

Published on 18th January 2012

Bioquell - provider of specialist low temperature, residue-free bio-decontamination and filtration technologies to the healthcare, life sciences and defence sectors – announces that it has been awarded a £1.2 million development contract relating to the new vehicle being developed by General Dynamics UK for the UK Ministry of Defence.

General Dynamics UK was awarded a contract by the UK Ministry of Defence for the Demonstration phase of the Specialist Vehicle (SV) Programme for the Reconnaissance Block 1 Vehicles and Common Base Platform in July 2010.

Bioquell UK Limited, a subsidiary of Bioquell PLC, develops and manufactures, among other things, Chemical, Biological, Radiological and Nuclear (CBRN) filtration systems as well as Environmental Control Systems (ECS).

General Dynamics has awarded Bioquell UK Limited a development contract worth approximately £1.2 million relating to ECS and CBRN systems for the demonstration phase of the SV Programme.

Once this initial development contract has been fulfilled, it is expected that contracts relating to the manufacture and in-service phases will be awarded and expected to run for at least five years.

Commenting on this contract award, Nick Adams, Group Chief Executive of Bioquell PLC, said:

“We are extremely pleased to have been awarded this prestigious development contract relating to the British Army’s new Specialist Vehicle programme

The information in this article was current at 27 Mar 2012

Keywords: Defence Sectors, Life Sciences

Other news and updates from Bioquell

05-Apr-2012

Bioquell - News - C-Tick Approval for HPV ‘Superbug Busting’ Technology

Bioquell, leading hydrogen peroxide vapour environmental bio-decontamination specialist, worked closely with Capella Science, its authorised agent in Australia, to ensure the C-Tick mark was achieved for a wide range of its products, including the popular Bioquell Q-10 and Bioquell Z-2 HPV suites.